-
Location
-
C/O Adamas Pharmaceuticals, Inc., 1900 Powell St., Suite 1000, Emeryville, CA
-
Summary
-
The estimated net worth of Spyros Papapetropoulos is at least $1.79M dollars as of September 2, 2025. Spyros Papapetropoulos is the Chief Medical Officer of Vigil Neuroscience, Inc. and owns shares of Vigil Neuroscience, Inc. (VIGL) stock worth about $1.15M. Spyros Papapetropoulos is the President and CEO, Director of Neuphoria Therapeutics Inc. and owns shares of Neuphoria Therapeutics Inc. (NEUP) stock worth about $613K. Spyros Papapetropoulos is the Director of Lipocine Inc. and owns shares of Lipocine Inc. (LPCN) stock worth about $23K.
-
Signature
-
/s/ Spyros Papapetropoulos